These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7843755

  • 21. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
    Amuchastegui CS, Remuzzi G, Perico N.
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
    [Abstract] [Full Text] [Related]

  • 22. Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside.
    Baylis C, Masilamani S, Losonczy G, Samsell L, Harton P, Engels K.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1135-41. PubMed ID: 7562480
    [Abstract] [Full Text] [Related]

  • 23. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1.
    Edwards DL, Arora CP, Bui DT, Castro LC.
    Am J Obstet Gynecol; 1996 Aug; 175(2):484-8. PubMed ID: 8765273
    [Abstract] [Full Text] [Related]

  • 24. Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats.
    Kemp PA, Gardiner SM, March JE, Bennett T, Rubin PC.
    Br J Pharmacol; 1994 Jan; 111(1):325-31. PubMed ID: 8012714
    [Abstract] [Full Text] [Related]

  • 25. Renal effects of an acute NaCl load in chronic nitric oxide blockade-induced hypertensive rats.
    Rodríguez-Pérez JC, Brenner BM.
    J Physiol Biochem; 1998 Sep; 54(3):127-33. PubMed ID: 10217208
    [Abstract] [Full Text] [Related]

  • 26. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
    Baylis C, Engels K, Samsell L, Harton P.
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F74-8. PubMed ID: 8430832
    [Abstract] [Full Text] [Related]

  • 27. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A.
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [Abstract] [Full Text] [Related]

  • 28. Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide.
    Nakamura T, Alberola AM, Granger JP.
    Hypertension; 1993 Jun; 21(6 Pt 2):956-60. PubMed ID: 8505106
    [Abstract] [Full Text] [Related]

  • 29. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production.
    Johnson RA, Freeman RH.
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):919-22. PubMed ID: 1285942
    [Abstract] [Full Text] [Related]

  • 30. The protective effect of glycine in cisplatin nephrotoxicity: inhibition with NG-nitro-L-arginine methyl ester.
    Li Q, Bowmer CJ, Yates MS.
    J Pharm Pharmacol; 1994 May; 46(5):346-51. PubMed ID: 8083804
    [Abstract] [Full Text] [Related]

  • 31. Deficient production of nitric oxide induces volume-dependent hypertension.
    Lahera V, Salazar J, Salom MG, Romero JC.
    J Hypertens Suppl; 1992 Dec; 10(7):S173-7. PubMed ID: 1291651
    [Abstract] [Full Text] [Related]

  • 32. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition.
    Manning RD, Hu L, Williamson TD.
    Hypertension; 1994 Jun; 23(6 Pt 2):951-6. PubMed ID: 8206634
    [Abstract] [Full Text] [Related]

  • 33. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.
    Carlström M, Brown RD, Edlund J, Sällström J, Larsson E, Teerlink T, Palm F, Wåhlin N, Persson AE.
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F362-70. PubMed ID: 18032548
    [Abstract] [Full Text] [Related]

  • 34. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.
    Fernández N, García JL, García-Villalón AL, Monge L, Gómez B, Diéguez G.
    Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904
    [Abstract] [Full Text] [Related]

  • 35. Renal vasodilation with L-arginine. Effects of dietary salt.
    Deng X, Welch WJ, Wilcox CS.
    Hypertension; 1995 Aug; 26(2):256-62. PubMed ID: 7635532
    [Abstract] [Full Text] [Related]

  • 36. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
    Gardiner SM, Compton AM, Kemp PA, Bennett T, Foulkes R, Hughes B.
    Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
    [Abstract] [Full Text] [Related]

  • 37. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Guan H, Cachofeiro V, Pucci ML, Kaminski PM, Wolin MS, Nasjletti A.
    Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
    [Abstract] [Full Text] [Related]

  • 38. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H, Vuolteenaho O, Leppäluoto J, Ruskoaho H.
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [Abstract] [Full Text] [Related]

  • 39. Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats.
    Danielson LA, Conrad KP.
    Circ Res; 1996 Dec; 79(6):1161-6. PubMed ID: 8943954
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors.
    Davisson RL, Shaffer RA, Johnson AK, Lewis SJ.
    Neuroscience; 1996 Jun; 72(4):881-7. PubMed ID: 8735216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.